Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation: is confirmation needed?

Correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Cohenet al

“…The work presented by Cohen et al represents a valuable contribution; however, we respectfully disagree with the editorial conclusion drawn by Dr Garbi and Dr Mariani where they posit the cost-effectiveness of PR in SMR does not need confirmation 9…”

Response to: Correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Armoiry and Connock

“…The Authors' reply: We read with interest the response of Armoiry and Connock to our editorial1 and to the Cohen et al paper2 it referred to. This response demonstrates the wide interest on cost-effectiveness of transcatheter edge-to-edge repair (TEER) in secondary mitral regurgitation.…”

Heartbeat: hypertension risk is higher when obesity onset occurs earlier in adult life

“…In the accompanying editorial, Garbi and Mariani4 discuss the complexities of cost-effectiveness analysis in the NHS system and point out that “the recently published UK National Institute for Heath and Care Excellence (NICE) clinical guidelines recommend TEER for secondary mitral regurgitation as well. Furthermore, as part of the development process of the NICE guidelines, a cost-effectiveness analysis complementary to the NHS England Commissioning through Evaluation (CtE) was performed.…”